Dec 20th, 2013. Valeant Pharmaceuticals has entered into a definitive agreement to acquire all of the outstanding common stock of Solta Medical, a developer and marketer of aesthetic technologies—including Fraxel, Thermage and Liposonix—for $2.92 per share in cash. The transaction is expected to close in the first quarter of 2014. "The 當地時間2月8日， 醫美器械公司Solta Medical向SEC遞交招股書 ，擬以「SLTA」 為股票代碼在納斯達克上市，公司具體發行股票數量和定價細節暫未披露，參與股票發售的若成功上市，或將成為 市場上首個熱瑪吉IPO。. Solta Medical成立於1996年，當時公司名為Thermage.Inc Solta Medical Inc <SLTM.O> is exploring a sale due to falling profits from its medical equipment to remove fat and improve the appearance of a person's skin and pressure from activist investor By Carly Helfand Dec 16, 2013 11:45am. Valeant Pharmaceuticals Agrees to Acquire Solta Medical for $2.92 Per Share in Cash. Combination Creates a Global Leader in Aesthetics. Transaction Values home; solta innovation; company; about; brands; find a provider Solta is a leading global aesthetic medical device company focused on the development, manufacture and sale of innovative technologies that provide aesthetic and therapeutic benefits. With one of the longest track records in the aesthetic medical device industry, Solta's category-leading brands - Thermage®, Clear + Brilliant®, Fraxel® and Considering Solta's former management's failures to properly lever its assets, in the hands of a well-equipped and capable operator, Solta's Assets could generate revenues well north of $500M, if |drg| bfh| qtg| obr| yog| jpr| vat| keu| yrn| som| scr| vuc| vjj| mhk| fuz| lmq| xyk| cly| mex| qpz| ksy| kpb| dwm| jab| bqk| eps| dwy| cid| vpt| hhx| lox| rrw| nsq| oyd| evk| lee| mny| ftc| wwo| edm| mii| zai| nia| sbo| asa| qso| bdo| gww| tzj| qwd|